| Product Code: ETC13307054 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Cell Gene Therapy Manufacturing Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Cell Gene Therapy Manufacturing Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Cell Gene Therapy Manufacturing Market Revenues & Volume, 2021 & 2031F |
3.3 North America Cell Gene Therapy Manufacturing Market - Industry Life Cycle |
3.4 North America Cell Gene Therapy Manufacturing Market - Porter's Five Forces |
3.5 North America Cell Gene Therapy Manufacturing Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Cell Gene Therapy Manufacturing Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 North America Cell Gene Therapy Manufacturing Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.8 North America Cell Gene Therapy Manufacturing Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 North America Cell Gene Therapy Manufacturing Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 North America Cell Gene Therapy Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Cell Gene Therapy Manufacturing Market Trends |
6 North America Cell Gene Therapy Manufacturing Market, 2021 - 2031 |
6.1 North America Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Cell Expansion Systems, 2021 - 2031 |
6.1.3 North America Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Gene Editing Platforms, 2021 - 2031 |
6.1.4 North America Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Cryopreservation Solutions, 2021 - 2031 |
6.1.5 North America Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Fill-Finish Services, 2020 - 2028 |
6.2 North America Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Bioreactor-Based Expansion, 2021 - 2031 |
6.2.3 North America Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Zinc Finger Nucleases, 2021 - 2031 |
6.2.4 North America Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Liquid Nitrogen Storage, 2021 - 2031 |
6.2.5 North America Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Sterile Filling and Packaging, 2021 - 2031 |
6.3 North America Cell Gene Therapy Manufacturing Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Cell Gene Therapy Manufacturing Market, Revenues & Volume, By CDMOs and Pharma Companies, 2021 - 2031 |
6.3.3 North America Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Research Laboratories, 2021 - 2031 |
6.3.4 North America Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Cell Banks and Biorepositories, 2021 - 2031 |
6.3.5 North America Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Hospitals and Clinical Centers, 2021 - 2031 |
6.4 North America Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Application, 2021 - 2031 |
6.4.2 North America Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Scalable Cell Therapy Manufacturing, 2021 - 2031 |
6.4.3 North America Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Genetic Modification for Therapies, 2021 - 2031 |
6.4.4 North America Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Long-Term Storage of CGT Products, 2020 - 2028 |
6.4.5 North America Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Final Product Delivery to Patients, 2020 - 2028 |
7 North America Cell Gene Therapy Manufacturing Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.2.1 United States (US) Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.2.2 Canada Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.2.3 Rest of North America Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.3 North America Cell Gene Therapy Manufacturing Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
7.3.1 United States (US) Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.3.2 Canada Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.3.3 Rest of North America Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.4 North America Cell Gene Therapy Manufacturing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.1 United States (US) Cell Gene Therapy Manufacturing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.2 Canada Cell Gene Therapy Manufacturing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.3 Rest of North America Cell Gene Therapy Manufacturing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5 North America Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5.1 United States (US) Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5.2 Canada Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5.3 Rest of North America Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Application, 2021 - 2031 |
8 North America Cell Gene Therapy Manufacturing Market Key Performance Indicators |
9 North America Cell Gene Therapy Manufacturing Market - Export/Import By Countries Assessment |
10 North America Cell Gene Therapy Manufacturing Market - Opportunity Assessment |
10.1 North America Cell Gene Therapy Manufacturing Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Cell Gene Therapy Manufacturing Market Opportunity Assessment, By Product Type, 2021 & 2031F |
10.3 North America Cell Gene Therapy Manufacturing Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
10.4 North America Cell Gene Therapy Manufacturing Market Opportunity Assessment, By End User, 2021 & 2031F |
10.5 North America Cell Gene Therapy Manufacturing Market Opportunity Assessment, By Application, 2021 & 2031F |
11 North America Cell Gene Therapy Manufacturing Market - Competitive Landscape |
11.1 North America Cell Gene Therapy Manufacturing Market Revenue Share, By Companies, 2022 |
11.2 North America Cell Gene Therapy Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here